Clinical trials for Graft versus host disease
34 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07166848Electrostimulation Study for Ocular Graft vs. Host DiseaseZhonghui K. Luo, MD, PhD · PI: Zhonghui Luo, MD, PhD
- RECRUITINGPhase 2NCT07246031BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell TransplantationBioPhoenix Co., Ltd. · PI: Xiaodong Mo, PhD
- RECRUITINGN/ANCT07184853Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHDFirst Affiliated Hospital of Zhejiang University
- RECRUITINGPhase 2NCT07118254A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)Lubris Bio Pty Ltd
- RECRUITINGPhase 4NCT06824103Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host DiseaseNovartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- RECRUITINGPhase 3NCT07047456Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBTAnhui Provincial Hospital · PI: Xiaoyu Zhu, Ph.D
- RECRUITINGPhase 2NCT06799195Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell TransplantationUniversity of Nebraska · PI: Moataz Ellithi, MBChB
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT07162688Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.Fujian Medical University · PI: Ting Yang, MD, PhD
- RECRUITINGNCT07314892Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).Medical University of Gdansk · PI: Jan Puchowski, MD
- RECRUITINGPhase 3NCT06615050A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)Incyte Corporation · PI: Incyte Medical Monitor
- RECRUITINGPhase 2NCT06756061Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher SeverityByung-Sik Cho
- RECRUITINGPhase 1NCT06392711Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical XerostomiaUniversity of Wisconsin, Madison · PI: Sara McCoy, MD, PhD
- RECRUITINGPhase 1NCT06008808Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell TransplantationWashington University School of Medicine · PI: Ramzi Abboud, M.D.
- ACTIVE NOT RECRUITINGPhase 3NCT06294678Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological MalignanciesAnhui Provincial Hospital · PI: Xiaoyu Zhu, ph.D
- ACTIVE NOT RECRUITINGN/ANCT06160986Horizons Chronic Graft-Versus-Host-Disease StudyUniversity of Miami · PI: Lara Traeger, PhD
- RECRUITINGPhase 1NCT05443425Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic MalignanciesCity of Hope Medical Center · PI: Monzr M. Al Malki
- RECRUITINGNCT05718791CXCL9 and EASIX for Prediction of Acute Graft Versus Host DiseaseHenry Ford Health System
- RECRUITINGPHASE1, PHASE2NCT05531786Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)National Cancer Institute (NCI) · PI: Najla El Jurdi, M.D.
- ACTIVE NOT RECRUITINGNCT04231500The Skin Microbiome in Graft Versus Host DiseaseUniversity Hospital, Basel, Switzerland · PI: Simon Mueller, PD Dr. med
- ACTIVE NOT RECRUITINGNCT05186857Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic TransplantFundación Pública Andaluza para la gestión de la Investigación en Sevilla · PI: Ildefonso Espigado, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT05090384Pediatric GVHD Low Risk Steroid Taper TrialJohn Levine · PI: John E Levine, MD, MS
- RECRUITINGN/ANCT05236062Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART TrialDana-Farber Cancer Institute · PI: Christina Dieli-Conwright
- ACTIVE NOT RECRUITINGPhase 3NCT04769895MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD PatientsMaaT Pharma · PI: Florent Malard, MD, PhD
- RECRUITINGEarly Phase 1NCT04744116Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host DiseaseM.D. Anderson Cancer Center · PI: Partow Kebriaei, MD
- RECRUITINGNCT04700657The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) PatientsIndiana University
- ACTIVE NOT RECRUITINGPhase 2NCT04198922Acalabrutinib for the Treatment of Chronic Graft Versus Host DiseaseFred Hutchinson Cancer Center · PI: Stephanie Lee, MD, MPH
- RECRUITINGNCT04660487Relationship Between "FODMAPs" and "GVHD"The First Affiliated Hospital of Soochow University · PI: Depei Wu
- ACTIVE NOT RECRUITINGN/ANCT03719092High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell TransplantOhio State University Comprehensive Cancer Center · PI: Hannah Choe, MD
- RECRUITINGN/ANCT04337515A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell TransplantChristopher Dvorak · PI: Christopher C Dvorak, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03924401Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantEmory University · PI: John Horan, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03983850Optimizing PTCy Dose and TimingNational Cancer Institute (NCI) · PI: Christopher G Kanakry, M.D.
- RECRUITINGNCT03602599Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy ControlsNational Institute of Dental and Craniofacial Research (NIDCR) · PI: Jacqueline W Mays, D.D.S.
- RECRUITINGNCT03148743FMT in Gut aGVHD TreatedThe First Affiliated Hospital of Soochow University · PI: depei wu
- RECRUITINGPhase 2NCT00603330Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft FunctionUniversity of Liege · PI: Yves Beguin, MD, PhD